Effects of a new type of calcium product (Seaweed-calcium complex: SWCa) and combination of SWCa and Ca-DTPA on removal of injected 239Pu were examined in rats. SWCa is a natural product consisting of mixed calcined oyster shell (COS) which is composed of calcium salt probably in the form of calcium oxide and a natural material extracted from seaweed to transport calcium actively throughout the small intestine. In experiment I, a 2% solution of SWCa, COS, CaO, CaC12 or CaCO3 was injected into the small intestinal loops of rats to compare the intestinal absorption rate of each calcium salt. In experiment II, 25 male Wistar rats, 3 months of age, were divided into five groups given; a control diet with 1% CaC03 (group A), a SWCa diet with 1% SWCa to replace the 1% CaC03 after plutonium injection (group B), a SWCa diet 1 week before plutonium injection until the end of the experiment (group C), a SWCa diet and intraperitoneal injections of a daily dose of 150umo/kg of Ca-DTPA (group D), and a control diet and intraperitoneal injections of the same dose of Ca-DTPA as group D (group E). The rats were injected intravenously with plutonium, 1.85x 104Bq/kg, and killed 14 days later and the femur and liver were excised. All excreta were collected at 24-h intervals during the experimental period. The plutonium concentration was measured by a liquid scintillation spectrometry after a wet ashing treatment.
I INTRODUCTION
Chelating agents such as DTPA (diethylenetriaminepentaacetic acid)1-3) and CBMIDA [catechol-3,6-bis(methyleiminodiacetic acid) 4 SWCa mixed with COS and the extracted material from seaweed produced a higher serum calcium level than COS, and the extracted material probably has a role to transport calcium actively from the small intestine.13) The intestinal absorption rate of calcium carbonate is higher than that of other calcium salts such as calcium acetate, calcium lactase, calcium glucose, calcium citrate and whole milk.14) Therefore, the bioavailability of SWCa was compared with that of COS, CaO, CaCl2 and CaC03 in this study.
We considered that the bioavailability of SWCa might be useful to reduce plutonium retention particularly in bone because the serum calcium level was increased rapidly and because SWCa, which had a high intestinal absorption rate, was deposited at the mineralizing front on the bone surface faster than plutonium thus inhibiting plutonium incorporation on it. In the present study, the effects of SWCa and combination of SWCa with Ca-DTPA on the removal of plutonium in rats after the intestinal absorption of calcium of SWCa was compared with those of COS, CaO, CaCl2 and CaC03.
II MATERIALS AND METHODS
In experiment I, the intestinal absorption rate of SWCa, COS, CaO, CaCl2 and CaC03 was examined in rats. Twenty four male Wistar rats, 3 months of age, were divided into three groups of eight each. Under the anesthesia of a combination of ketamine hydrochloride and xylazine, the abdominal wall was incised and the proximal duodenum and distal ileum were tied with thread to make an intestinal loop. Five ml of a 2 solution of SWCa, COS, CaO, CaCl2 or CaC03, pH adjusted to 7, was injected into the small intestinal loop. Blood samples of 0.6ml were collected before injection, 15 and 30min later from a vena cava posterior to measure the prevalues of total and ionic calcium in serum. Blood was clotted and centrifuged for 15min at 3,000 r.p.m. The concentration of total serum calcium was determined by the o-cresolphthalein complexone method (Wako Pure Chemical Industries, Ltd.) and ionic serum calcium by an ion electrode method (Sera 250, Horiba Ltd.).
In experiment II, the effect of orally administered SWCa on the removal of injected plutonium was examined in rats. SWCa (1%) was used to replace CaC03 (1%) in the control diet (MB-1, Funabashi Co., Ltd.).
Twenty five male Wistar rats, 3 months of age, with a mean body weight of 299g, were deviled into the following five groups of five each: group A was given a control diet, group B was switched to a SWCa diet immediately after plutonium injection, group C was given a SWCa diet from 1 week before plutonium injection until the end of the experiment, group D was switched to a SWCa diet immediately after plutonium injection and injected intraperitoneally with a daily dose of 150pmol/kg of body weight of Ca-DTPA once a day for 14 days, beginning at about 1h after plutonium injection on the first day of treatment, and group E was given a control diet and injected Ca-DTPA according to the same schedule as group D.
Rats were injected intravenously with plutonium i.e., 5.6x103 Bq of 239Pu, in 0.12ml of 0 .008M sodium citrate (1.85x104Bq/kg), pH adjusted to 7.2, under anesthesia consisting of a combination of ketamine hydrochloride and xylazine in an airtight box with gloves designed for plutonium administration to a small animal. The plutonium-injected arts were then put in individual metabolic cages designed to separate urine and feces and placed in an airtight box for small animal breeding. All excreta were collected at 24-h intervals during the experiment.
Rats were killed 14 days after plutonium injection. The femur and liver were excised. Each sample was weighed and treated for the wet ashing. The whole femur, about 0.5g of liver, 0.5g of stirred feces, and 0.5ml of urine were each placed in a glass beaker on a hot plate for wet ashing. Nitric acid was added repeatedly until the color of the residue disappeared completely. Finally, 2ml of mixed solution (nitric acid : distilled water: hydrofluoric acid=150:100: 0.9) was added to a beaker and 1ml of the solution was pipetted in a counting vial. The alpha activity of plutonium in a vial was measured by an alpha liquid scintillation counter for 30min. Recovery and counting efficiency were confirmed by an alpha-spectrometry using an electrodeposited sample which was made of the same plutonium source as that used in this method.
III RESULTS
In experiment I, the levels of both total and ionic serum calcium in the SWCa group were elevated rapidly and were significantly higher than those in the COS, CaO, CaC12 and CaCO3 groups 15 min after the injection (Fig. I (a) and (b) ). Figure 2 (a) and (b) show the plutonium contents of the entire skeleton and liver to the administered dose in each group in experiment II. The plutonium content of the entire skeleton was calculated from the amount of plutonium in the femur which is often used as a convenient index of the total skeleton burden, by multiplying the plutonium content of both femurs by 10.15) As shown in Fig. 2 , the plutonium content to the administered dose in the skeleton was 69.3, 63.6, 58.9, 10.4, 19.0% for groups A, B, C, D and E and that in the liver was 7.74, 6.93, 6.43, 0.22, and 0.35% for groups A, B, C, D and E, respectively. Figure 3 (a), (b), (c) and (d) show the plutonium content in the urine and feces. There were increases in plutonium contents in the urine and feces during the first 2-3 days after plutonium injection.
IV DISCUSSION
The finding obtained in experiment I that the levels of total ionic serum calcium were elevated more rapidly and were higher by SWCa administration than by COS, CaO, CaCl2 and CaCO3, indicated that the material extracted from seaweed in the SWCa transported actively the calcium of COS throughout the small intestine of the rats. This material is under further examination. The serum calcium value after oral administration of SWCa was higher than that after administration of CaCO3 in beagle dogs. 13) In experiment II, the plutonium content in the skeleton in groups B, C and E administered SWCa was lower than those in groups A and D administered CaCO3. The difference in plutonium content in the skeleton was 5.7% between group A and group B, and 8.6% between group D and group E. These findings indicated that the plutonium contents was lowered by oral administration of SWCa after plutonium injec- Each value shows the percent to the pre-injection level. Each mark and vertical bar represents the mean+SD for eight rats.
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The difference between group A and group C was 10.4% and higher than that between groups A and B, or between groups D and E, which indicated that preventive administration of SWCa was more effective to reduce the plutonium content in the skeleton than the post-plutonium administration.
The amount of plutonium in the skeleton lowered by SWCa administration was less than that by Ca-DTPA.
Plutonium was distributed initially both on the resting and active bone surfaces.15) The percentage of newly formed bone (active bone surface x mineral apposition rate) to total trabecular bone measured by bone histo- Pu O SWCa after Pu morphometry in 3-month-old male rats of the same strain used in this study during this experiment was calculated to be about 12% from the findings reported previously.16) Therefore, the rates (5.7 and 8.6%) of reduction in plutonium content in the skeleton in the SWCa administered groups might be comparable to that in the CaCO3-administered groups. This finding supports our view that excessive serum calcium deposits on the mineralizing surface and inhibits the incorporation of plutonium.
The difference (8.7%) between group D and group E administered Ca-DTPA was larger than that (5.7%) between group A and group B. The action of Ca-DTPA to lower the plutonium content was independent of the content of calcium. The amount of incorporated plutonium was lower in group D than in group E probably because the Ca-DTPA compounded with plutonium which could not deposit on the mineralizing front by the inhibition of calcium-deposition (Fig. 4) . A possible explanation for the reduction in the plutonium content in the skeleton by the elevation of serum calcium is that the excessive calcium induced by the rapidly and highly elevated serum calcium level at least within 15min after SWCa administration reached the bone and was deposited in the mineralizing front of the bone surface earlier than the injected plutonium and inhibited the incorporation of plutonium (Fig. 4) , because about half of the intravenously injected plutonium was deposited on the endosteal bone surface 2-24h later and the plutonium was buried gradually into the bone matrix accompanied by slow bone turnover in rats. 15, 17) Bone metabolism is produced by an equal balance between the osteoclast activity resolving an old bone and osteoblast activity forming :a new bone. As the increase in serum calcium rapidly destroyed the osteoclasts and resulted in the decrease of temporary bone formation and mineralization by osteoblasts, plutonium could not deposit. The decrease in the number of osteoclasts may also contribute to the reduction of plutonium incorporation by phagocytosis.1) SWCa administration had a beneficial effect to lower the plutonium contents in the liver for an unknown reason. The mechanism of the reduction of plutonium incorporation in the liver remains to be elucidated.
The removal of plutonium by bioavailability of natural products might help resolve troublesome problems such as the difficulty of practical use and the avoidable toxicity of chelating agents. In the chelation therapy, DTPA application to humans is recommended within 30min after exposure. However, plutonium-contamined persons may not be able to receive chelation therapy easily or promptly because the assessment of plutonium intake and special medical handling by medical doctors will take many hours.9) However, the contamined person can take oral SWCa immediately after exposure and also continue to take it during the protracted treatment, because SWCa is present in a powder form which can be taken orally.
An interresting finding is that the effect to lower the plutonium contents in the skeleton and liver was increased by the preventive administration of SWCa as compared with the administration after plutonium injection in this study. Also a combination of SWCa and DTPA may be expected to decrease the dose and toxicity of DTPA.
V CONCLUSION SWCa was demonstrated to be effective to lower the plutonium contents in the skeleton and liver by oral administration both before and after plutonium exposure. The effect was increased by the pre-administration of SWCa and by the combination of SWCa and Ca-DTPA. 
